Impact of estrogen therapy on lymphocyte homeostasis and the response to seasonal influenza vaccine in post-menopausal women

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Engelmann, Flora ^a   Rivera, Andrea ^a   Park, Byung ^b   Messerle Forbes, Marci ^c   Jensen, Jeffrey T ^c,d   Messaoudi, Ilhem ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; ESTRADIOL; IMMUNOGLOBULIN G; INFLUENZA VACCINE; INTERLEUKIN DERIVATIVE; PROGESTERONE;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTRACEPTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION PREVENTION; LYMPHOCYTE COUNT; LYMPHOCYTE PRESERVATION; LYMPHOCYTE SUBPOPULATION; MENSTRUAL CYCLE; MIDDLE AGED; POSTMENOPAUSE; SEASONAL INFLUENZA; YOUNG ADULT; ADVERSE EFFECTS; ANTIBODY PRODUCTION; BLOOD; CD4 LYMPHOCYTE COUNT; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LYMPHOCYTE; MENOPAUSE; PHYSIOLOGY;

ANTIBODY FORMATION; CD4 LYMPHOCYTE COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOMEOSTASIS; HUMANS; INFLUENZA VACCINES; INTERLEUKINS; LYMPHOCYTE COUNT; LYMPHOCYTES; MENOPAUSE; MIDDLE AGED; PROGESTERONE;

EID: 84959243345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149045     Document Type: Article

References (68)

1. Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R, Tarkowski A (1992) Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 144: 190-202.
2. Delpy L, Douin-Echinard V, Garidou L, Bruand C, Saoudi A, Guery JC (2005) Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J Immunol 175: 5050-5057.
3. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancyrelated relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339: 285-291.
4. Verthelyi D, Klinman DM (2000) Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo. Immunology 100: 384-390.
5. Angstwurm MW, Gartner R, Ziegler-Heitbrock HW (1997) Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 9: 370-374.
6. Al-Harthi L, Wright DJ, Anderson D, Cohen M, Matity Ahu D, Cohn J, et al. (2000) The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res 20: 719-724.
7. Franklin RD, Kutteh WH (1999) Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. J Reprod Immunol 42: 93-106.
8. Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, et al. (2002) Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 169: 566-574.
9. Suenaga R, Evans MJ, Mitamura K, Rider V, Abdou NI (1998) Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J Rheumatol 25: 1305-1312.
10. Verthelyi DI, Ahmed SA (1998) Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cell Immunol 189: 125-134.
11. Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou NI (2001) Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 28: 2644-2649.
12. Evans MJ, MacLaughlin S, Marvin RD, Abdou NI (1997) Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNFalpha production in SLE but not in normal cultures. Clin Immunol Immunopathol 82: 258-262.
13. Paavonen T, Andersson LC, Adlercreutz H (1981) Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogenstimulated cultures. J Exp Med 154: 1935-1945.
14. Kanda N, Tamaki K (1999) Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 103: 282-288.
15. Karpuzoglu E, Zouali M (2009) The multi-faceted influences of estrogen on lymphocytes: Toward novel immuno-interventions strategies for autoimmunity management. Clin Rev Allergy Immunol 40: 16-26.
16. Kim WU, Min SY, Hwang SH, Yoo SA, Kim KJ, Cho CS (2010) Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus. Clin Exp Immunol 161: 453-458. doi: 10.1111/j.1365-2249.2010.04194.x
17. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H (2006) Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res 84: 370-378.
18. Khan D, Dai R, Karpuzoglu E, Ahmed SA (2010) Estrogen increases, whereas IL-27 and IFN-gamma decrease, splenocyte IL-17 production in WT mice. Eur J Immunol 40: 2549-2556. doi: 10.1002/eji. 201040303
19. Kovats S, Carrera E, Agarwal H (2010) Sex Steroid receptors in Immune Cells. In: Klein SL, Roberts CW, editors. Sex Hormones and Immunity to Infection. Berlin: Springer. pp. 53-91.
20. Butts CL, Shukair SA, Duncan KM, Bowers E, Horn C, Belyavskaya E, et al. (2007) Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol 19: 287-296.
21. Hughes GC, Thomas S, Li C, Kaja M-K, Clark EA (2008) Cutting Edge: Progesterone Regulates IFN-{alpha} Production by Plasmacytoid Dendritic Cells. J Immunol 180: 2029-2033.
22. Calippe B, Douin-Echinard V, Delpy L, Laffargue M, Lelu K, Krust A, et al. (2010) 17Beta-estradiol promotes TLR4-Triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J Immunol 185: 1169-1176. doi: 10.4049/jimmunol.0902383
23. McElhaney JE, Effros RB (2009) Immunosenescence: what does it mean to health outcomes in older adults? Current Opinion in Immunology 21: 418-424. doi: 10.1016/j.coi.2009.05.023
24. Gameiro CM, Romao F, Castelo-Branco C (2010) Menopause and aging: changes in the immune system-A review. Maturitas 67: 316-320. doi: 10.1016/j.maturitas.2010.08.003
25. Gameiro C, Romao F (2010) Changes in the immune system during menopause and aging. Front Biosci (Elite Ed) 2: 1299-1303.
26. Carroll ML, Yerkovich ST, Pritchard AL, Davies JM, Upham JW (2011) Adaptive immunity to rhinoviruses: sex and age matter. Respir Res 11: 184.
27. Klein SL, Jedlicka A, Pekosz A (2010) The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 10: 338-349. doi: 10.1016/S1473-3099(10)70049-9
28. Jansen R, Batista S, Brooks AI, Tischfield JA, Willemsen G, van Grootheest G, et al. (2014) Sex differences in the human peripheral blood transcriptome. BMC Genomics 15: 33. doi: 10.1186/1471-2164-15-33
29. Baeza I, De Castro NM, Arranz L, Fdez-Tresguerres J, De la Fuente M (2011) Ovariectomy causes immunosenescence and oxi-inflamm-Ageing in peritoneal leukocytes of aged female mice similar to that in aged males. Biogerontology 12: 227-238. doi: 10.1007/s10522-010-9317-0
30. Baeza I, De Castro NM, Gimenez-Llort L, De la Fuente M (2010) Ovariectomy, a model of menopause in rodents, causes a premature aging of the nervous and immune systems. J Neuroimmunol 219: 90-99. doi: 10.1016/j.jneuroim.2009.12.008
31. Engelmann F, Barron A, Urbanski H, Neuringer M, Kohama SG, Park B, et al. (2010) Accelerated immune senescence and reduced response to vaccination in ovariectomized female rhesus macaques. Age (Dordr).
32. Pennock JW, Stegall R, Bell B, Vargas G, Motamedi M, Milligan G, et al. (2009) Estradiol improves genital herpes vaccine efficacy in mice. Vaccine 27: 5830-5836. doi: 10.1016/j.vaccine.2009.07.052
33. Deguchi K, Kamada M, Irahara M, Maegawa M, Yamamoto S, Ohmoto Y, et al. (2001) Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause 8: 266-273.
34. Vural P, Canbaz M, Akgul C (2006) Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers. Pharmacol Res 53: 367-371.
35. Vural P, Akgul C, Canbaz M (2006) Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res 54: 298-302.
36. Saucedo R, Rico G, Basurto L, Ochoa R, Zarate A (2002) Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response. Gynecol Obstet Invest 53: 114-117.
37. De Martinis M, Franceschi C, Monti D, Ginaldi L (2005) Inflamm-Ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 579: 2035-2039.
38. Kumru S, Godekmerdan A, Yilmaz B (2004) Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J Reprod Immunol 63: 31-38.
39. Giglio T, Imro MA, Filaci G, Scudeletti M, Puppo F, De Cecco L, et al. (1994) Immune cell circulating subsets are affected by gonadal function. Life Sci 54: 1305-1312.
40. Porter VR, Greendale GA, Schocken M, Zhu X, Effros RB (2001) Immune effects of hormone replacement therapy in post-menopausal women. Exp Gerontol 36: 311-326.
41. Nguyen DC, Masseoud F, Lu X, Scinicariello F, Sambhara S, Attanasio R (2011) 17beta-Estradiol restores antibody responses to an influenza vaccine in a postmenopausal mouse model. Vaccine 29: 2515-2518. doi: 10.1016/j.vaccine.2011.01.080
42. Hsu HC, Scott DK, Zhang P, Zhou J, Yang P, Wu Q, et al. (2006) CD8 T-cell immune phenotype of successful aging. Mech Ageing Dev 127: 231-239.
43. Agematsu K (2000) Memory B cells and CD27. Histol Histopathol 15: 573-576.
44. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. (2000) Inflamm-Aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: 244-254.
45. Weiskopf D, Weinberger B, Grubeck-Loebenstein B (2009) The aging of the immune system. Transplant International 22: 1041-1050. doi: 10.1111/j.1432-2277.2009.00927.x
46. Wagner WM, Ouyang Q, Sekeri-Pataryas K, Sourlingas TG, Pawelec G (2004) Basic biology and clinical impact of immunosenescence. Biogerontology 5: 63-66.
47. Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, et al. (2003) Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: A contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 38: 981-987.
48. Effros RB (2005) The role of CD8 T cell replicative senescence in human aging. Discov Med 5: 293-297.
49. McNerlan SE, Rea IM, Alexander HD (2002) A whole blood method for measurement of intracellular TNF-Alpha, IFN-gamma and IL-2 expression in stimulated CD3+ lymphocytes: differences between young and elderly subjects. Exp Gerontol 37: 227-234.
50. Sandmand M, Bruunsgaard H, Kemp K, Andersen-Ranberg K, Schroll M, Jeune B (2003) High circulating levels of tumor necrosis factor-Alpha in centenarians are not associated with increased production in T lymphocytes. Gerontology 49: 155-160.
51. Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39: 687-699.
52. Vasto S, Carruba G, Lio D, Colonna-Romano G, Di Bona D, Candore G, et al. (2009) Inflammation, ageing and cancer. Mech Ageing Dev 130: 40-45. doi: 10.1016/j.mad.2008.06.003
53. Brooks-Asplund EM, Tupper CE, Daun JM, Kenney WL, Cannon JG (2002) Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women. Cytokine 19: 193-200.
54. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176: 6333-6339.
55. Clements ML, Murphy BR (1986) Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 23: 66-72.
56. Al-Harthi L, Kovacs A, Coombs RW, Reichelderfer PS, Wright DJ, Cohen MH, et al. (2001) A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. Aids 15: 1535-1543.
57. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL Jr., et al. (2001) Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185: 380-385.
58. Kaushic C, Ashkar AA, Reid LA, Rosenthal KL (2003) Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 77: 4558-4565.
59. Calder AE, Hince MN, Dudakov JA, Chidgey AP, Boyd RL (2011) Thymic involution: where endocrinology meets immunology. Neuroimmunomodulation 18: 281-289. doi: 10.1159/000329496
60. Stopinska-Gluszak U, Waligora J, Grzela T, Gluszak M, Jozwiak J, Radomski D, et al. (2006) Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J Reprod Immunol 69: 65-75.
61. Salem ML (2004) Estrogen, a double-edged sword: modulation of TH1-And TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 3: 97-104.
62. Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, et al. (2001) Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age-And menopauserelated changes. Exp Gerontol 36: 547-557.
63. Yasui T, Maegawa M, Tomita J, Miyatani Y, Yamada M, Uemura H, et al. (2007) Changes in serum cytokine concentrations during the menopausal transition. Maturitas 56: 396-403.
64. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303: 1195-1198.
65. Jentes ES, Poumerol G, Gershman MD, Hill DR, Lemarchand J, Lewis RF, et al. (2011) The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis 11: 622-632. doi: 10. 1016/S1473-3099(11)70147-5
66. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG (2001) Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64: 262-268.
67. La Gruta NL, Kedzierska K, Stambas J, Doherty PC (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85: 85-92.
68. Bluming AZ, Tavris C (2009) Hormone replacement therapy: real concerns and false alarms. Cancer J 15: 93-104. doi: 10.1097/PPO.0b013e31819e332a